RxDoctor Payments Data

Jennifer Plenty

Psychiatric/Mental Health · Phoenix, AZNPI 1437878659

Payments from drug & device makers

$1,720in general payments, 2019–2025

Across 77 payments — averaging $22.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$263
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$253
  • AbbVie$238
  • Johnson & Johnson$224
  • Vanda Pharmaceuticals Inc.$180
  • Neurocrine Biosciences, Inc.$136
  • plus $426 from 7 others

What the payments were for

  • Food & beverage$1,58692%
  • Education$1348%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,720 in reported general payments places this provider in the 75th percentile of 1,230 psychiatric/mental health providers in Arizona.

See all psychiatric/mental health providers in Arizona

Medicare billing

Part B allowed, 2024
$15,404
Medicare patients
44
Services billed
149

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate55$165,497
VraylarCariprazine Hcl54$67,735
SpravatoEsketamine Hcl15$18,460
AtivanLorazepam15$9,346
Divalproex Sodium ErDivalproex Sodium105$6,367
Clozapine81$5,645
Doxepin Hcl81$3,690
Quetiapine Fumarate167$3,384
Trazodone Hcl162$2,594
Gabapentin113$2,332
Divalproex Sodium33$2,237
Buspirone Hcl116$2,009
Hydroxyzine Hcl59$1,833
Prazosin Hcl67$1,680
Fluoxetine Hcl105$1,619

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Spravato$224$183,95770 claims
AbbVieVraylar$238$67,73554 claims
Almatica Pharma LLCSertraline Hcl$59$43973 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,230 psychiatric/mental health providers in Arizona.

Other psychiatric/mental health in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →